NasdaqCM:ASTHHealthcare
Astrana Health (ASTH) Could Be 32% Undervalued Following Its Recent Pullback
Astrana Health (ASTH) has caught investor attention after a sharp pullback, with the share price down about 9% in the past day and roughly 12% over the past month.
The latest pullback sits against a mixed backdrop for Astrana Health, with the share price return up 36% year to date but recent momentum fading over the past quarter. The 1-year total shareholder return of 15.14% contrasts with a 5-year total shareholder loss of 64.41%.
Scan the pullback in Astrana Health against other potential...